To continue using this website, please tell us a
little about yourself:

This site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about cookies on the website and how to delete cookies, see our Privacy and Cookie Policy.

I accept the FE Trustnet cookie policy

For more information Click here

Login

Register

It's look like you're leaving us

What would you like us to do with the funds you've selected

Show me all my options Forget them Save them
Customise this table

Polar Capital Global Healthcare Growth and Income PLC

Change Share Class?

Select Performance Currency
Pound Sterling
  • What is the Fund’s objective?

    To generate capital growth and income by investing in a global portfolio of healthcare stocks.

    How does FE rate this fund?

    • No FE Alpha managers
    • 2
    • Not included in the AFI

    Who manages this fund?

    Dan Mahony Since 15-Jun-2010

    Daniel joined Polar Capital to set up the healthcare team in 2007. He has 23 years of industry experience, comprising...

    Co-manager

    Gareth Powell Since 15-Jun-2010

    Gareth joined Polar Capital in 2007 to set up the healthcare team. He has over 15 years’ investment experience in the...

    Co-manager

  • How has this fund performed?

    Cumulative Performance chart

    Cumulative Performance as at 23/09/2016
        3m 6m 1yr 3yrs 5yrs
    Polar Capital Global Healthcare Growth and... +20.1 +21.5 +17.2 +44.1 +105.7
    Biotechnology & Healthcare +22.8 +23.9 +9.1 +75.6 +231.2
    NAV +18.1 +20.2 +18.6 +55.2 +131.7

    Discrete Performance chart

  • Forensic News Alerts

  • Ratios and Analysis

    How does this fund compare against other funds in Biotechnology & Healthcare?

    Quartile Ranking

        1y 3y
    ? Position 1 / 4 4 / 4
    ? Quartile 1 4

    Ranking is for the main unit within the sector View other funds in this sector

    Other Rating

    Mstar Analyst
    Rating

    Ratio Info

        1y 3y
    ? Volatility 12.59 12.10
    ? Alpha 12.73 5.30
    ? Beta 0.34 0.38
    ? Sharpe 0.76 0.79
    ? Info Ratio 0.64 -0.37
    ? R2 0.47 0.42
    ? Quartiles:1 2 3 4

    Risk Score

    FE Risk scores allow you to see how risky a fund is in comparison with the FTSE 100.

    This fund: 132
    FTSE 100: 100
    Cash: 0

    Investment Details

    Charges
    Initial n/a
    Annual 0.85%
    ? TER 1.14%
    Minimum Investment?
    Initial n/a
    Additional n/a
  • Prices and Codes

    Prices

                Diluted NAV   Div yield
      Currency Bid Offer Date Prem/Disc Estimated Last Published Gearing Net Gross
    Polar Capital Global Healthcare Growth and Income PLC Ord 25p GBX 195.00 23 Sep 2016 -6.43 207.33 207.33 100 2.03 2.03

    Codes

      Unit type Exchange TIDM Citicode SEDOL ISIN
    Polar Capital Global Healthcare Growth and Income PLC Ord 25p INC London PCGH K0P0 B6832P1 GB00B6832P16
  • What does this fund invest in?

    Asset Class Breakdown (31 Aug 2016)

    Rank Asset %    
    1 US Equities 45.30
    2 UK Equities 13.30
    3 Swiss Equities 12.30
    4 International Equities 8.30
    5 Japanese Equities 6.10
    6 French Equities 3.60
    7 Irish Equities 3.30
    8 Israeli Equities 3.30
    9 German Equities 3.20
    10 Money Market 1.30

    Top Holdings (31 Aug 2016)

    Rank Largest Holdings %  
    1 Pfizer 7.60
    2 Merck & Co 7.20
    3 Novartis 7.10
    4 AstraZeneca 5.00
    5 Johnson & Johnson 5.00
    6 GlaxoSmithKline 4.70
    7 Roche 4.60
    8 Astellas Pharma 4.00
    9 Sanofi 3.60
    10 Teva Pharmaceutical Industries 3.30
  • Additional Information

    Additional Information

    Legal Structure: INVT
    Nominal value: 25
    Fund Launch: 15-Jun-2010
    Unit Launch: 15-Jun-2010
    Savings plan: NO
    Last AGM: 27-Jan-2016
    Stockbroker(s): N/A
    Wind-up date: N/A
    Dividend policy: N/A
    Settlement Details: N/A
    Exchange: London
    Issued: 120,475,000
    Asset Class: Equity
    Annual accounts: N/A
    Next AGM: January 2017
    Management Contract: N/A
    Continuation/Wind-up provision: N/A
    Investment Restrictions: N/A
    Tax Policy: N/A
    Fund Size: £234.3m / $303.8m (22-Sep-16)
    Market Value: £ 233.72m
    Own ISA wrapper: NO
    Last report / accounts: 10-May-2016
    EGM: N/A
    Borrowing limits: N/A
    Splits: N/A
    Reconstruction proposal: N/A
    News: company announcements
  • News and Research about this fund

    Relevant articles

    Relevant Guides

  • Contact Details

    +44 (0) 20 7227 2799 (Fax Number)
    +44 (0) 20 7227 2700 (Main Number)

Annual Management Charges: 0.85% of Market Cap/or NAV which ever is lower;

All prices in Pence Sterling (GBX) unless otherwise specified. Price total return performance figures are calculated using closing mid prices and with net income (dividends) reinvested. NAV total return performance figures are calculated using fully diluted (where applicable) daily estimated NAV figures from Thomson Financial Datastream. Performance figures are shown in Pound Sterling (GBP). You can switch the fund’s native currency using the currency selector towards the top of this page.

Your custom layout changed and saved automatically
Drag and drop the icon to customise your factsheet layout
Data provided by FE. Care has been taken to ensure that the information is correct, but FE neither warrants, represents nor guarantees the contents of information, nor does it accept any responsibility for errors, inaccuracies, omissions or any inconsistencies herein. Past performance does not predict future performance, it should not be the main or sole reason for making an investment decision. The value of investments and any income from them can fall as well as rise.

You are currently using an old browser which will not be supported by Trustnet after 31/07/2016. To ensure you benefit from all features on the site, please update your browser.   Close